169 related articles for article (PubMed ID: 32363681)
1. Risk of incident dementia following metformin initiation compared with noninitiation or delay of antidiabetic medication therapy.
Salas J; Morley JE; Scherrer JF; Floyd JS; Farr SA; Zubatsky M; Barthold D; Dublin S
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):623-634. PubMed ID: 32363681
[TBL] [Abstract][Full Text] [Related]
2. Metformin and Sulfonylurea Use and Risk of Incident Dementia.
Scherrer JF; Salas J; Floyd JS; Farr SA; Morley JE; Dublin S
Mayo Clin Proc; 2019 Aug; 94(8):1444-1456. PubMed ID: 31378227
[TBL] [Abstract][Full Text] [Related]
3. Association Between Metformin Initiation and Incident Dementia Among African American and White Veterans Health Administration Patients.
Scherrer JF; Morley JE; Salas J; Floyd JS; Farr SA; Dublin S
Ann Fam Med; 2019 Jul; 17(4):352-362. PubMed ID: 31285213
[TBL] [Abstract][Full Text] [Related]
4. Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study.
Roumie CL; Min JY; D'Agostino McGowan L; Presley C; Grijalva CG; Hackstadt AJ; Hung AM; Greevy RA; Elasy T; Griffin MR
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28424149
[TBL] [Abstract][Full Text] [Related]
5. Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes.
Orkaby AR; Cho K; Cormack J; Gagnon DR; Driver JA
Neurology; 2017 Oct; 89(18):1877-1885. PubMed ID: 28954880
[TBL] [Abstract][Full Text] [Related]
6. Glycemic and weight changes after persistent use of incident oral diabetes therapy: a Veterans Administration retrospective cohort study.
Huizinga MM; Roumie CL; Greevy RA; Liu X; Murff HJ; Hung AM; Grijalva CG; Griffin MR
Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1108-12. PubMed ID: 20878643
[TBL] [Abstract][Full Text] [Related]
7. Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.
Roumie CL; Greevy RA; Grijalva CG; Hung AM; Liu X; Murff HJ; Elasy TA; Griffin MR
JAMA; 2014 Jun; 311(22):2288-96. PubMed ID: 24915260
[TBL] [Abstract][Full Text] [Related]
8. Deintensification of Diabetes Medications among Veterans at the End of Life in VA Nursing Homes.
Niznik JD; Hunnicutt JN; Zhao X; Mor MK; Sileanu F; Aspinall SL; Springer SP; Ersek MJ; Gellad WF; Schleiden LJ; Hanlon JT; Thorpe JM; Thorpe CT
J Am Geriatr Soc; 2020 Apr; 68(4):736-745. PubMed ID: 32065387
[TBL] [Abstract][Full Text] [Related]
9. Mortality among veterans with type 2 diabetes initiating metformin, sulfonylurea or rosiglitazone monotherapy.
Wheeler S; Moore K; Forsberg CW; Riley K; Floyd JS; Smith NL; Boyko EJ
Diabetologia; 2013 Sep; 56(9):1934-43. PubMed ID: 23797633
[TBL] [Abstract][Full Text] [Related]
10. Initiation of sulfonylureas versus metformin is associated with higher blood pressure at one year.
Roumie CL; Liu X; Choma NN; Greevy RA; Hung AM; Grijalva CG; Griffin MR
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):515-23. PubMed ID: 22431419
[TBL] [Abstract][Full Text] [Related]
11. Use of oral diabetes medications and the risk of incident dementia in US veterans aged ≥60 years with type 2 diabetes.
Tang X; Brinton RD; Chen Z; Farland LV; Klimentidis Y; Migrino R; Reaven P; Rodgers K; Zhou JJ
BMJ Open Diabetes Res Care; 2022 Sep; 10(5):. PubMed ID: 36220195
[TBL] [Abstract][Full Text] [Related]
12. No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes.
Wu CY; Wang C; Saskin R; Shah BR; Kapral MK; Lanctôt KL; Herrmann N; Cogo-Moreira H; MacIntosh BJ; Edwards JD; Swardfager W
J Intern Med; 2024 Jan; 295(1):68-78. PubMed ID: 37747779
[TBL] [Abstract][Full Text] [Related]
13. Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.
Roumie CL; Min JY; Greevy RA; Grijalva CG; Hung AM; Liu X; Elasy T; Griffin MR
CMAJ; 2016 Apr; 188(6):E104-E112. PubMed ID: 26811361
[TBL] [Abstract][Full Text] [Related]
14. Historical cohort analysis of treatment patterns for patients with type 2 diabetes initiating metformin monotherapy.
Hazel-Fernandez L; Xu Y; Moretz C; Meah Y; Baltz J; Lian J; Kimball E; Bouchard J
Curr Med Res Opin; 2015; 31(9):1703-16. PubMed ID: 26154837
[TBL] [Abstract][Full Text] [Related]
15. Incident dementia risk among patients with type 2 diabetes receiving metformin versus alternative oral glucose-lowering therapy: an observational cohort study using UK primary healthcare records.
Doran W; Tunnicliffe L; Muzambi R; Rentsch CT; Bhaskaran K; Smeeth L; Brayne C; Williams DM; Chaturvedi N; Eastwood SV; Dunachie SJ; Mathur R; Warren-Gash C
BMJ Open Diabetes Res Care; 2024 Jan; 12(1):. PubMed ID: 38272537
[TBL] [Abstract][Full Text] [Related]
16. Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models.
Farmer RE; Ford D; Mathur R; Chaturvedi N; Kaplan R; Smeeth L; Bhaskaran K
Int J Epidemiol; 2019 Apr; 48(2):527-537. PubMed ID: 30753459
[TBL] [Abstract][Full Text] [Related]
17. Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study.
Raebel MA; Xu S; Goodrich GK; Schroeder EB; Schmittdiel JA; Segal JB; O'Connor PJ; Nichols GA; Lawrence JM; Kirchner HL; Elston Lafata J; Butler M; Newton KM; Steiner JF
Ann Pharmacother; 2013 Oct; 47(10):1280-91. PubMed ID: 24259692
[TBL] [Abstract][Full Text] [Related]
18. Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study.
Raebel MA; Ellis JL; Schroeder EB; Xu S; O'Connor PJ; Segal JB; Butler MG; Schmittdiel JA; Kirchner HL; Goodrich GK; Lawrence JM; Nichols GA; Newton KM; Pathak RD; Steiner JF
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):699-710. PubMed ID: 24639086
[TBL] [Abstract][Full Text] [Related]
19. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.
Currie CJ; Poole CD; Gale EA
Diabetologia; 2009 Sep; 52(9):1766-77. PubMed ID: 19572116
[TBL] [Abstract][Full Text] [Related]
20. Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.
Cheung KS; Chan EW; Wong AYS; Chen L; Seto WK; Wong ICK; Leung WK
J Natl Cancer Inst; 2019 May; 111(5):484-489. PubMed ID: 30329127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]